Top Articles - Finance

One of the first mistakes that a lot of investors make is not diversifying their investment portfolio.

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

By selecting only a few companies to invest in or by investing in only one industry investors are basic

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ally putting all of their eggs in one basic. If that industry fails then all of the investments made by

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

the investor will suffer. To avoid this problem it is recommended that you invest in at least 10 diffe

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ent industries and that you invest in at least 20 different companies. If you invest in bonds you may w

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ant to stagger their maturity dates. If you don’t want to try and diversify your portfolio on your own

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

you can enlist the help of an investment professional or you can diversify your investment portfolio by

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

investing in mutual funds.

Another mistake that many investors make is trying to time the market. One

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

of the biggest timing mistakes that people make is to invest in popular stocks after their stock price

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

has increased significantly. Another timing mistake is selling a stock when you think it is about to dr

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

op in value. Few laypeople can judge when a stock will drop in value, and fewer can judge when they sho

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

uld reinvest. Because of this you can loose out on investment gains your investment would have received

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

had you just let your investment ride. While trying to time the market doesn’t always lead to losses, y

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ou can improve your chances of correctly timing the market by relying on the guidance of a professional

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

financial advisor or investment specialist.

The third mistake that a lot of investors make is not rei

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

nvesting their money after they make a sale. Many investors, in fact, keep their assets in cash after t

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ey make a sale. They do this because they are intimidated by the investment process or because they sim

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ply don’t know what other investments they should try. Again to avoid this problem you should turn to y

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

our investment specialist. They will be able to help you set up investment goals and they will be able

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

to help you invest and reinvest your money in products that will help you to reach your financial goals

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102252/toparticles-Common-Investing-Mistakes-and-How-to-Avoid-Them.html">Common Investing Mistakes and How to Avoid Them</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102252/toparticles-Common-Investing-Mistakes-and-How-to-Avoid-Them.html]Common Investing Mistakes and How to Avoid Them[/url]

Headlines play a crucial role in the success of your business. Your subject line must get your prospect interested enough to read your copy! An effective headline, whether in an email, ad or book, will literally force your potential customers to want to learn more.

Baby Boomers developed in careers where if they didn't work harder or smarter than the next person, they could easily be replaced, or eliminated altogether. Therefore, they worked with their noses to the grindstone and strug-gled to pull themselves up the next rung of the proverbial ladder. Millennials are not as interested in putting extra time and effort in to achieve promotions like Boomers are. They enjoy the flexibility of a corporate lattice, not ladder. They want to move up, down, or laterally when it suits their life.

The Philippines call center industry is booming. Smart companies are catching on. Writer for Global Sky Inc, a Philippines based call center offering US Quality at Offshore rates.

Tags

Links

Top Articles - Common Investing Mistakes and How to Avoid Them

Related Articles: